| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100882 | Journal of Crohn's and Colitis | 2008 | 7 Pages |
Abstract
Thirty mg/day of 6-MP or 50Â mg/day of AZA, once-daily oral administration in Japanese IBD patients was sufficient to achieve the therapeutic target level of 6-TGN in Europeans/Americans.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Takako Komiyama, Tomoharu Yajima, Rie Kubota, Yasushi Iwao, Atsushi Sakuraba, Shinsuke Funakoshi, Kenichi Negishi, Ikuko Minami, Yoichi Tanaka, Hiroshi Mae, Toshifumi Hibi,